lonafarnib has been researched along with bradykinin in 1 studies
Studies (lonafarnib) | Trials (lonafarnib) | Recent Studies (post-2010) (lonafarnib) | Studies (bradykinin) | Trials (bradykinin) | Recent Studies (post-2010) (bradykinin) |
---|---|---|---|---|---|
224 | 34 | 90 | 14,195 | 355 | 1,520 |
Protein | Taxonomy | lonafarnib (IC50) | bradykinin (IC50) |
---|---|---|---|
B2 bradykinin receptor | Homo sapiens (human) | 0.0018 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nestler, HP | 1 |
1 other study(ies) available for lonafarnib and bradykinin
Article | Year |
---|---|
Hit to Lead Success Stories--IBC Conference: Effective chemistry strategies for reducing attrition rates and speeding lead compounds into the pipeline. 31 January-1 February 2005, San Diego, CA, USA.
Topics: Aniline Compounds; Bradykinin; Drug Approval; Drug Design; Drug Evaluation; Humans; Molecular Structure; Piperidines; Propionates; Pyridines; Time Factors | 2005 |